{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Waco",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "74623",
      "recalling_firm": "Allergan Sales, LLC",
      "address_1": "8301 Mars Dr",
      "address_2": "N/A",
      "postal_code": "76712-6578",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0100-2017",
      "product_description": "TAZORAC (tazarotene) Gel 0.05%, Rx only, packaged in 15 x 3.5 g professional sample containers, Manufactured by: Allergan Inc., Irvine, CA 92512. UPC: 300238335159.",
      "product_quantity": "17,112 tubes",
      "reason_for_recall": "Failed Content Uniformity Specifications",
      "recall_initiation_date": "20160630",
      "center_classification_date": "20161013",
      "termination_date": "20171206",
      "report_date": "20161019",
      "code_info": "Lot # 85037; Exp 05/17  Lot # 82583; Exp 10/16"
    }
  ]
}